This week, Pfizer and French vaccine company, Valneva, released phase 3 clinical trial data for PF-0730740, a four-dose Lyme disease vaccine they developed together that is about 70% effective. While ...

Pfizer started 2026 on a high note despite ongoing skepticism from retail investors. Its key anti-cancer drugs, Padcev, Lorbrena, and Talzenna, showed strong performance in Q4. Accordingly, sales of ...

Pfizer (PFE) paid $9.771B in dividends against free cash flow of $9.076B in FY2025, exceeding cash generation by $695M, while its GAAP payout ratio stands at 126.5% and total debt rose to $67.4B as ...

Princeton Digital Group (PDG), which develops and operates data centres in Singapore, Japan, India, Indonesia, China, Malaysia and South Korea, has announced a strategic multi-site acquisition in ...

Pfizer has underperformed the market in each of the past three years. The stock is doing well of late as investors have been turning to safer investments amid uncertainty. Pfizer has been struggling ...

An experimental Lyme disease vaccine from Pfizer PFE0.40%increase; green up pointing triangle and Valneva VLA 0.93%increase; green up pointing triangle didn’t conclusively succeed in a large study, ...

A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the ...

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result as fewer-than-expected infections in the pivotal study made its potency ...

Pfizer said it will seek regulatory approval for a Lyme disease vaccine candidate despite failing a late-stage trial. Pfizer said not enough people contracted Lyme disease to be confident in the ...

(WXYZ) — In today’s Health Alert, Pfizer’s Lyme vaccine shows strong protection in a phase 3 clinical trial, but misses a key study goal. Meanwhile, experts say ...

Pharmaceutical giant Pfizer PFE1.28%increase; green up pointing triangle and French vaccine maker Valneva VLA 0.29%increase; green up pointing triangle reported positive topline results from their ...

March 23 (Reuters) - Pfizer (PFE.N), opens new tab and Valneva (VLS.PA), opens new tab said on Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed ...